These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2339364)

  • 21. Quantitative and qualitative congenital deficiency of antithrombin III: a new molecular variant called ATIII-Barcelona 2.
    Fontcuberta J; Grau E; Rubio N; Félez J; Rutllant ML
    Thromb Res; 1988 Jul; 51(1):75-81. PubMed ID: 3413737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High and low anticoagulant activity heparins. Preparation in large scale and degree of complexation with antithrombin III.
    Takahashi HK; Nader HB; Dietrich CP
    Arzneimittelforschung; 1985; 35(11):1620-3. PubMed ID: 4091864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immobilization of heparin with trichloro-s-triazine: purification of mouse antithrombin.
    Finlay TH; Troll V; Hodgins LT
    Anal Biochem; 1980 Nov; 108(2):354-9. PubMed ID: 7457881
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies on antithrombin III. I. Purification and some properties of antithrombin III (ATIII), and the relationship between plasma antithrombin activity and ATIII antigen concentration (author's transl)].
    Takahashi K
    Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):879-88. PubMed ID: 7234301
    [No Abstract]   [Full Text] [Related]  

  • 25. [Separation and purification of antithrombin III, thrombin and carboxypeptidase N using affinity sorption on the copolymer hydroxyalkylmethacrylate with immobilized heparin (heparinoid)].
    Rybák M; Coupek J
    Cesk Farm; 1982 Jan; 31(1):27-9. PubMed ID: 6176339
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of the in vivo hemorrhagic and antithrombotic effects of a low antithrombin-III affinity heparin fraction.
    Ockelford PA; Carter CJ; Cerskus A; Smith CA; Hirsh J
    Thromb Res; 1982 Sep; 27(6):679-90. PubMed ID: 7179209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and further characterization of antithrombin III Milano: lack of reactivity with thrombin.
    Wolf M; Boyer-Neumann C; Meyer D; Tripodi A; Mannucci PM; Larrieu MJ
    Thromb Haemost; 1987 Oct; 58(3):888-92. PubMed ID: 3433251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Membrane chromatography for rapid purification of recombinant antithrombin III and monoclonal antibodies from cell culture supernatant.
    Lütkemeyer D; Bretschneider M; Büntemeyer H; Lehmann J
    J Chromatogr; 1993 Jun; 639(1):57-66. PubMed ID: 8331144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AT III Barcelona: a familial quantitative-qualitative AT III deficiency.
    Grau E; Fontcuberta J; Félez J; de Diego I; Soto R; Rutllant ML
    Thromb Haemost; 1988 Feb; 59(1):13-7. PubMed ID: 3363529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel matrix for high performance affinity chromatography and its application in the purification of antithrombin III.
    Zhao R; Luo J; Shangguan D; Liu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):175-81. PubMed ID: 15664348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis.
    Lane DA; Lowe GD; Flynn A; Thompson E; Ireland H; Erdjument H
    Br J Haematol; 1987 Aug; 66(4):523-7. PubMed ID: 3663509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induced binding of proteins by ammonium sulfate in affinity and ion-exchange column chromatography.
    Arakawa T; Tsumoto K; Ejima D; Kita Y; Yonezawa Y; Tokunaga M
    J Biochem Biophys Methods; 2007 Apr; 70(3):493-8. PubMed ID: 17210183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Isolation and characteristics of antithrombin III from human plasma].
    Markova OA; Kalashnikov VV; Khvatov VB
    Vopr Med Khim; 1987; 33(3):62-6. PubMed ID: 3630019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromatography of heparin on sepharose-lysine: molecular size fractionation and its relevance to thrombin and antithrombin III binding.
    Hatton MW; Berry LR; Kaur H; Koj A; Regoeczi E
    Can J Biochem; 1979 Oct; 57(10):1183-90. PubMed ID: 120212
    [No Abstract]   [Full Text] [Related]  

  • 35. Expression and characterization of human antithrombin III synthesized in mammalian cells.
    Wasley LC; Atha DH; Bauer KA; Kaufman RJ
    J Biol Chem; 1987 Oct; 262(30):14766-72. PubMed ID: 3667601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three novel high performance affinity chromatographic media for the separation of antithrombin III from human plasma.
    Zhao Y; Zhao R; Shangguan D; Xiong S; Liu G
    Biomed Chromatogr; 2001 Dec; 15(8):487-92. PubMed ID: 11748680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Separation of heparin on Sepharose CL-4B in the presence of high concentrations of ammonium sulphate.
    Uchiyama H; Fujimoto N; Sakurai K; Nagasawa K
    J Chromatogr; 1984 Mar; 287(1):55-66. PubMed ID: 6725457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fractionation of heparin using antithrombin III reversibly bound to concanavalin A-sepharose.
    Denton J; Lewis WE; Nieduszynski IA; Phelps CF
    Anal Biochem; 1981 Dec; 118(2):388-91. PubMed ID: 7337233
    [No Abstract]   [Full Text] [Related]  

  • 39. Purification and characterization of guinea pig antithrombin III.
    Clement LT
    Prep Biochem; 1983; 13(1):1-20. PubMed ID: 6856582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-step chromatographic procedure for purification of basic fibroblast growth factor from recombinant Escherichia coli and characterization of the equilibrium parameters of adsorption.
    Seeger A; Rinas U
    J Chromatogr A; 1996 Oct; 746(1):17-24. PubMed ID: 8885384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.